D. E. Shaw & Co., Inc. Eucrates Biomedical Acquisition Corp. Transaction History

D. E. Shaw & Co., Inc.

  • $98.6 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$9.85 - $9.91 $1.6 Million - $1.61 Million
162,000 Added 32.13%
666,171 $6.6 Million
Q1 2022

May 16, 2022
BUY
$9.76 - $9.85 $248,899 - $251,194
25,502 Added 5.33%
504,171 $4.97 Million
Q4 2021

Feb 14, 2022
BUY
$9.75 - $9.85 $2.95 Million - $2.98 Million
302,988 Added 172.46%
478,669 $4.67 Million
Q3 2021

Nov 15, 2021
BUY
$9.65 - $9.99 $527,333 - $545,913
54,646 Added 45.15%
175,681 $1.72 Million
Q2 2021

Aug 16, 2021
BUY
$9.69 - $10.22 $1.17 Million - $1.24 Million
121,035 New
121,035 $1.19 Million

About Eucrates Biomedical Acquisition Corp.

EUCR Quotes by TradingView
  • Ticker EUCR
  • Exchange
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,459,100
More about EUCR
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email